HELEN GILLMOR, District Judge.
Plaintiffs J.E., through his parent, Suzanne Egan, and the Hawaii Disability Rights Center filed a Complaint alleging that the State of Hawaii, Department of Human Services, violated provisions of the Medicaid Act, 42 U.S.C. § 1396 et seq.
Plaintiffs claim that the Department of Human Services has been precluding the state Medicaid program from covering Applied Behavior Analysis ("ABA") as a treatment for autistic children and young adults, in violation of the Medicaid Act's early and periodic screening, diagnostic, and treatment ("EPSDT") services mandate. Plaintiffs also allege that the Department has failed to inform eligible persons that ABA is an available early and periodic screening, diagnostic, and treatment service.
Plaintiffs seek a declaratory ruling stating that:
(1) the State of Hawaii, through the Department of Human Services, violated the Medicaid Act by failing to cover ABA treatment pursuant to the EPSDT services mandate;
Plaintiffs also seek an injunction:
(2) ordering the Department to include ABA as a covered treatment under the state Medicaid program for persons eligible for EPSDT services;
(3) compelling the Department to publicize the Medicaid program's coverage of ABA treatment; and
(4) instructing the Department to submit a State Plan Amendment memorializing a policy that adds ABA treatment as a covered EPSDT benefit.
Defendant seeks dismissal of Plaintiffs' action as moot and declaratory judgment in its favor as to the following:
(1) the Department has always covered medically necessary autism treatment under Medicaid law;
(2) the Department does not have an obligation pursuant to the Medicaid Act to inform persons eligible for EPSDT services about ABA treatment; and
(3) the Defendant is not required to submit a State Plan Amendment to the Centers for Medicare and Medicaid Services that specifically memorializes coverage for ABA treatment.
Plaintiffs' Motion for Summary Judgment (ECF No. 100) and Defendant's Motion for Summary Judgment (ECF No. 98) are each
On September 5, 2014, Plaintiffs J.E. and the Hawaii Disability Rights Center (collectively, "Plaintiffs") filed a Complaint. (ECF No. 1).
On December 1, 2014, Plaintiffs filed their First Amended Complaint. (ECF No. 8).
On June 19, 2015, the Magistrate Judge approved a stipulation by the parties for Plaintiffs to file a Second Amended Complaint. (ECF No. 42).
On June 22, 2015, Plaintiffs filed a Second Amended Complaint. (ECF No. 44).
On July 6, 2015, Defendant Rachael Wong, Director of the State of Hawaii, Department of Human Services ("Defendant") filed a Motion to Dismiss Plaintiffs' Second Amended Complaint. (ECF No. 46).
On August 27, 2015, the Court denied Defendant's Motion to Dismiss. (ECF No. 62).
On December 10, 2015, Plaintiffs filed a Motion for Class Certification. (ECF No. 78).
On February 10, 2016, Plaintiffs filed PLAINTIFFS' MOTION FOR SUMMARY JUDGMENT and PLAINTIFF'S CONCISE STATEMENT OF FACTS IN SUPPORT OF PLAINTIFFS' MOTION FOR SUMMARY JUDGMENT. (ECF Nos. 100; 101).
On February 10, 2016, Defendant filed DEFENDANT RACHAEL WONG, IN HER OFFICIAL CAPACITY AS DIRECTOR OF THE STATE OF HAWAII, DEPARTMENT OF HUMAN SERVICE'S MOTION FOR SUMMARY JUDGMENT and SEPARATE AND CONCISE STATEMENT OF FACTS IN SUPPORT OF DEFENDANT'S MOTION FOR SUMMARY JUDGMENT. (ECF Nos. 98; 99). On the same date, Defendant also filed a Motion to Seal Exhibits 4, 7, 8, and 9. (ECF No. 97).
On February 19, 2016, Plaintiffs filed PLAINTIFFS' AMENDED CONCISE STATEMENT OF FACTS. (ECF No. 104). On the same date, Defendant filed DEFENDANT RACHAEL WONG, IN HER OFFICIAL CAPACITY AS DIRECTOR OF THE STATE OF HAWAII, DEPARTMENT OF HUMAN SERVICE'S FIRST AMENDED SEPARATE AND CONCISE STATEMENT OF FACTS IN SUPPORT OF DEFENDANT'S MOTION FOR SUMMARY JUDGMENT. (ECF No. 103).
On February 19, 2016, the Court granted Defendant's Motion to Seal Exhibits 4, 7, 8, and 9. (ECF No. 105).
On February 23, 2016, the Magistrate Judge filed a Findings and Recommendation to deny Plaintiffs' Motion for Class Certification. (ECF No. 108).
On March 10, 2016, Defendant filed DEFENDANT RACHAEL WONG'S, IN HER OFFICIAL CAPACITY AS DIRECTOR OF THE STATE OF HAWAII, DEPARTMENT OF HUMAN SERVICES, MEMORANDUM IN OPPOSITION TO PLAINTIFFS' MOTION FOR SUMMARY JUDGMENT. (ECF No. 109). On the same date, Defendant also filed DEFENDANT RACHAEL WONG'S, IN HER OFFICIAL CAPACITY AS DIRECTOR OF THE STATE OF HAWAII, DEPARTMENT OF HUMAN SERVICES, STATEMENT IN OPPOSITION TO PLAINTIFFS' AMENDED CONCISE STATEMENT OF FACTS IN SUPPORT OF PLAINTIFFS' MOTION FOR SUMMARY JUDGMENT. (ECF No. 110).
On March 10, 2016, Plaintiffs filed PLAINTIFFS' MEMORANDUM IN OPPOSITION TO [ECF NO. 98] DEFENDANT RACHAEL WONG, IN HER OFFICIAL CAPACITY AS DIRECTOR OF THE STATE OF HAWAII, DEPARTMENT OF HUMAN SERVICES' MOTION FOR SUMMARY JUDGMENT, FILED FEBRUARY 10, 2016. (ECF No. 111). On the same date, Plaintiffs also filed PLAINTIFFS' CONCISE STATEMENT OF FACTS IN OPPOSITION TO DEFENDANT'S MOTION FOR SUMMARY JUDGMENT. (ECF No. 112).
On March 17, 2016, the Court adopted the Magistrate Judge's Findings and Recommendation to deny Plaintiffs' Motion for Class Certification. (ECF No. 113).
On April 25, 2016, the Plaintiffs filed PLAINTIFFS' REPLY IN SUPPORT OF [ECF NO. 100] MOTION FOR SUMMARY JUDGMENT. (ECF No. 118). On the same date, Defendant filed DEFENDANT RACHAEL WONG, IN HER OFFICIAL CAPACITY AS DIRECTOR OF THE STATE OF HAWAII, DEPARTMENT OF HUMAN SERVICE'S REPLY IN SUPPORT OF HER MOTION FOR SUMMARY JUDGMENT. (ECF No. 117).
On May 5, 2016, the Court held a hearing on the parties' cross-motions for summary judgment. (ECF No. 119). At the hearing, the Court instructed the parties to file supplemental memoranda addressing the Hawaii Disability Rights Center's standing.
On May 13, 2016, Defendant filed DEFENDANT RACHAEL WONG, IN HER OFFICIAL CAPACITY AS DIRECTOR OF THE STATE OF HAWAII, DEPARTMENT OF HUMAN SERVICE'S SUPPLEMENTAL BRIEF ON HAWAII DISABILITY RIGHTS CENTER'S STANDING. (ECF No. 120).
On May 20, 2016, Plaintiffs filed PLAINTIFFS' RESPONSE TO DEFENDANT'S SUPPLEMENTAL MEMORANDUM ON STANDING OF THE HAWAII DISABILITY RIGHTS CENTER. (ECF No. 122).
Plaintiff J.E. ("J.E.") is a seven-year-old boy who was first diagnosed with autism spectrum disorder ("autism") at age four.
The Hawaii Disability Rights Center ("the HDRC") is a non-profit "Protection and Advocacy" organization that serves Hawaii's disabled residents. (Erteschik Supp. Decl. at ¶ 3, ECF No. 122-1). A Protection and Advocacy organization defends and supports the legal and human rights of individuals with disabilities.
The HDRC has constituents instead of members. (
The State of Hawaii, Department of Human Services ("the Department") is the agency responsible for administering the Medicaid program in Hawaii.
Under the managed care system, the Department contracts with third-party health plans to provide Medicaid coverage to eligible beneficiaries. (
Prior to August 2014, the Department did not view Applied Behavior Analysis ("ABA") as an effective form of treatment for autism.
In January 2013, the State's Legislative Reference Bureau published a report regarding ABA coverage. Citing to an interview with the Department's Medicaid administrator, Dr. Kenneth Fink ("Dr. Fink"), the report stated that ABA treatment was not covered by Medicaid, as it was not considered "evidence[]-based and, therefore, not medically necessary." (Ex. 6 of Plas Amended CSF, ECF No. 104-9).
In April 2013, the then-director of the Department, Patricia McManaman ("Director McManaman"), testified before the state legislature in opposition to a bill that would require health insurers to provide coverage for ABA. Director McManaman stated that ABA treatment was "not currently covered by the Hawaii Medicaid program." (Ex. 7 of Plas. Amended CSF at p. 1, ECF No. 104-10).
In October 2013, a physician at Shriners Hospital for Children evaluated J.E.'s autism and prescribed J.E. be treated for his autism by receiving 20 hours of ABA treatment per week. (Ex. 1 of Plas. Amended CSF at Bates Nos. E00544-47, ECF No. 104-4).
On November 10, 2013, a psychologist from a separate healthcare provider recommended that J.E. receive ABA to "increase manding
At the end of 2013, J.E.'s mother conducted her own research as to whether Hawaii's Medicaid program covered ABA treatment. (Egan Decl. at ¶¶ 14; 20-21, ECF No. 104-2). As part of her investigation, she spoke with Leolinda Parlin, a "Medicaid Ombudsman," ("Medicaid Ombudsman Parlin") about ABA. (
In December 2013, J.E. was enrolled in an ABA treatment program with a private ABA provider. (
On March 19, 2014, Director McManaman again presented testimony before the state legislature. She expressed support "for the intent of the coverage" of ABA treatment, but questioned whether sufficient evidence to support the effectiveness of ABA existed at that time. (Mar. 19, 2014 Testimony of Director McManaman at pp. 2-3, Ex. 12 of Plas. Amended CSF, ECF No. 104-15).
In late March 2014, J.E.'s mother spoke with the private ABA provider about Medicaid coverage of J.E.'s ABA treatment. Based on her discussions with the provider, J.E.'s mother continued to believe that such a claim would be denied. (Egan Decl. at ¶ 26). The private ABA provider nonetheless submitted claims for J.E.'s ABA treatment to his Medicaid health plan. J.E.'s Medicaid health plan paid for his ABA treatment at the private ABA provider from March through August 2014.
From March through May 2014, J.E. continued to receive 6-10 hours of ABA treatment at the private provider. (Plas. Ans. to Def. Interrogatories at p. 4, Ex. 10 of Def. Amended CSF).
Beginning in June 2014, J.E. began to receive 20 hours of ABA treatment at the private provider. (
On July 14, 2014, a second psychologist recommended that J.E. undergo 35-40 hours of ABA treatment per week. (Ex. 1 of Plas. Amended CSF at Bates Nos. E00034-35).
In August 2014, J.E. stopped attending the private provider's ABA treatment program. (Plas. Ans. to Def. Interrogatories at p. 4, Ex. 10 of Def. Amended CSF). According to J.E.'s mother, the private provider "had staffing issues that could not accommodate the frequency and intensity of services . . . and upon inquiry to Medicaid I could not get any confirmation that I could rely on future payment for J.E.'s continued minimal ABA services." (Egan Decl. at ¶ 30).
In August 2014, the federal Agency for Healthcare Research and Quality published a report on autism. The report discussed various autism treatment studies, concluding that ABA is evidence-based and "can positively affect a subset of children with [autism]." (Ex. 15 of Plas. Amended CSF at p. 9, ECF No. 104-18).
Dr. Fink reviewed the August 2014 report and surmised that based on its analysis, sufficient research existed to conclude that ABA treatment is evidence-based, and therefore may qualify as medically necessary for Medicaid coverage purposes. (Fink Depo. at 159:14-161:8, Ex. 2 of Plas. Amended CSF). Dr. Fink began plans to articulate a formal policy that included guidance as to ABA provider certification requirements, Medicaid coverage limits, and who may qualify for coverage of ABA treatment. (Aug. 26, 2014 E-Mail from Dr. Fink, Ex. 17 of Plas. Amended CSF, ECF No. 104-20).
In September 2014, the national Centers for Medicare & Medicaid Services issued an informational bulletin that clarified the federal agency's position on ABA treatment. The bulletin stated that the agency was not mandating ABA treatment, emphasizing that ABA "is one treatment modality for ASD [autism spectrum disorder]. CMS is not endorsing or requiring any particular treatment modality for ASD. State Medicaid agencies are responsible for determining what services are medically necessary for eligible individuals." (Ex. 19 of Plas. Amended CSF at p. 1, ECF No. 104-20).
On November 14, 2014, J.E. restarted his ABA treatment. (Egan Decl. at ¶ 35). He received 15 hours of ABA a week at Easter Seals Hawaii (Pacific Autism Center) ("Easter Seals"). (
In early December 2014, officials from the Department of Human Services drafted a one-page memorandum that directed health plans to consider covering ABA treatment. The memorandum was sent to Dr. Fink for his review. (Ex. 21 of Plas. Amended CSF at Bates No. DHS 2467, ECF No. 104-24). On December 8, Dr. Fink sent an e-mail rejecting the draft memorandum. (
On December 18, 2014, the Department of Human Service's Medicaid Medical Director, Dr. Curtis Toma, informed the Medicaid health plans' medical directors that "[p]atients with Autistic Spectrum Disorder can benefit from Applied Behavior Analysis (ABA) therapy. We are currently working on draft guidance regarding ABA and would appreciate any feedback on your part." (Dec. 18, 2014 E-Mail from Dr. Curtis Toma, Ex. 22 of Plas. Amended CSF, ECF No. 104-25; Fink Depo. at 90:15-91:15, Ex. 2 of Plas. Amended CSF). The Department's Medicaid Medical Director also indicated that the Department had sought feedback from other state agencies as well. (Dec. 18, 2014 E-Mail from Dr. Curtis Toma, Ex. 22 of Plas. Amended CSF).
In January 2015, the Governor of Hawaii proposed an increase in the Department's budget for fiscal years 2016 and 2017 by $5.6 million and $5.5 million, respectively. (Amendments to 2015-2017 Exec. Biennium Budget, Ex. 24 of Plas. Amended CSF, ECF No. 104-27). The budget increase was meant to account for the expected increase in services for Medicaid recipients with autism, including ABA treatment. (
On January 13, 2015, the Department issued a memorandum to Medicaid health plans and service providers suggesting that the Department viewed ABA treatment favorably. Citing to the August 2014 report by the federal Agency for Healthcare Research and Quality, the memorandum concluded that ABA treatment is effective. (Ex. 12 of Def. Amended CSF at Bates No. DHS 5852, ECF No. 103-15). The memorandum provided general instructions as to how autism treatment claims may be processed. The memorandum contained information regarding appropriate billing codes for autism treatments. The memorandum did not request any action by the health plans for notification of patients of the change in the Department's position. It stated, "[w]e will be working with the community to make revisions to this clarification guidance." (
In February 2015, J.E.'s mother could not afford to continue paying for J.E.'s ABA treatment, and removed him from the Easter Seals program. (Egan Decl. at ¶ 38).
On approximately July 1, 2015, Easter Seals became a Medicaid-approved provider. (Tawata Decl. at ¶ 6, ECF No. 103-3).
In August 2015, J.E.'s mother re-enrolled him with Easter Seals. (Plas. Ans. to Def. Interrogatories at p. 5, Ex. 10 of Def. Amended CSF; Egan Decl. at ¶ 43). Since August 2015, J.E. has been receiving 35-40 hours of ABA treatment per week. (Egan Decl. at ¶ 44). J.E.'s Medicaid health plan has been paying for the entirety of his ABA treatment.
On August 28, 2015, the Department sent a new memorandum to its Medicaid health plans and service providers, replacing the January 13, 2015 memorandum. The memorandum stated that "Hawaii's [Medicaid] health plans must comply with the full range of EPSDT duties and requirements, . . . including ABA [treatment], for children under 21 years of age with [autism], when based on individualized determinations of medical necessity." (Ex. 13 of Def. Amended CSF at p. 1, ECF No. 103-16). The superseding memorandum included four attachments: A, B, C, and D:
Attachment A was a ten-page document that provided detailed information regarding how ABA treatment coverage should be assessed by the Medicaid health plans.
Attachment B was a flow chart that outlined the state's approved process for assessing ABA treatment.
Attachment C was a twelve-page document that delineated the billing codes and rates for autism services, including ABA.
Attachment D was a four-page document that included a sample claim form and accompanying instructions.
(
On December 22, 2015, the state Department of Budget and Finance added $4.9 million to the Department of Human Services's budget for fiscal year 2017. (2017 Exec. Supp. Budget, Ex. 31 of Plas. Amended CSF, ECF No. 104-34). The added amount was designated towards autism-related treatments for Medicaid beneficiaries. (
There is no evidence that the Department of Human Services has notified or instructed its health plans to inform eligible persons of the Department's reversal on its position as to Applied Behavior Analysis.
Summary judgment is appropriate when there is no genuine issue as to any material fact and the moving party is entitled to judgment as a matter of law. Fed. R. Civ. P. 56(c). To defeat summary judgment there must be sufficient evidence that a reasonable jury could return a verdict for the nonmoving party.
The moving party has the initial burden of "identifying for the court the portions of the materials on file that it believes demonstrate the absence of any genuine issue of material fact."
If the moving party meets its burden, then the opposing party may not defeat a motion for summary judgment in the absence of probative evidence tending to support its legal theory.
The court views the facts in the light most favorable to the non-moving party.
42 U.S.C. § 1983 ("Section 1983") provides a private cause of action to enforce a Medicaid beneficiary's right to early and periodic screening, diagnostic and treatment ("EPSDT") services.
Here, Plaintiffs J.E. and the Hawaii Disability Rights Center ("the HDRC") seek the following relief:
(1) A declaratory ruling that the State of Hawaii, through the Department of Human Services ("the Department"), violated the Medicaid Act by failing to cover Applied Behavior Analysis ("ABA") treatment pursuant to the EPSDT services mandate;
(2) An injunction:
(Plas. Motion for Summary Jdgmt. at p. 38, ECF No. 100-1).
Plaintiffs' request for declaratory relief is retrospective in nature; it concerns the Department's past conduct regarding a failure to cover ABA under the state's Medicaid program. Absent a waiver from the State, the Court may not impose retrospective relief pursuant to the Eleventh Amendment.
Article III of the United States Constitution requires plaintiffs to have standing for courts to adjudicate their claims.
The HDRC has associational standing in this case. Plaintiffs have produced evidence establishing that (1) at least one of the HDRC's constituents, J.E., would have standing to sue on his own; (2) Medicaid coverage of autism treatments are germane to the HDRC's mission as a Protection and Advocacy organization; and (3) neither the claim asserted nor the relief requested requires the HDRC's constituents to participate in the lawsuit.
Congress established Medicaid as a cooperative federal-state program, through which the federal government provides financial aid to states that furnish medical assistance to eligible low-income individuals.
States are not required to participate in the Medicaid program. Participating states, however, must comply with the requirements of the Medicaid Act, 42 U.S.C. § 1396 et seq., and regulations interpreting the statute.
To qualify for federal funding, a participating state must submit and have approved a "[s]tate plan" for "medical assistance," 42 U.S.C. § 1396a(a), that contains a comprehensive statement describing the nature and scope of the state's Medicaid program. 42 C.F.R. § 430.10.
The Medicaid Act defines "medical assistance" as "payment of part or all of the cost of . . . care and services" included in a list of 29 mandatory and optional categories. 42 U.S.C. § 1396d(a); 42 U.S.C. § 1396a(a)(10)(A).
One mandatory category of "medical assistance" concerns "early and periodic screening, diagnostic, and treatment [`EPSDT'] services . . . for individuals who are eligible under the plan and are under the age of 21." 42 U.S.C. § 1396d(a)(4)(B).
If a condition or illness is discovered through EPSDT screening, the EPSDT mandate requires a state's Medicaid program to provide coverage of treatments that "correct or ameliorate defects and physical and mental illnesses and conditions[,] . . . whether or not such services are covered under the State plan." 42 U.S.C. § 1396d(r)(5);
Congress deliberately crafted an "extremely broad" EPSDT mandate to ensure that the poorest children and young adults have access to modern medical services.
Each participating state has the authority to determine which treatments are medically necessary, so long as those restrictions are reasonable and are consistent with the Medicaid Act and its goal "of providing a broad range of health-sustaining services."
The Department of Human Services of the State of Hawaii considers a treatment medically necessary if it (1) is used for a medical condition, (2) is supported by "sufficient evidence" to demonstrate that the treatment can be expected to produce its intended effects on health outcomes, (3) has beneficial effects on heath outcomes that outweigh expected harmful effects, and (4) is the most cost-effective method available to address the medical condition. Haw. Admin. R. 1700.1-2. Evidence is considered sufficient "if it is peer-reviewed, is well-controlled, directly or indirectly relates the intervention to health outcomes, and is reproducible both within and outside of research settings."
A participating state fails to comply with the EPSDT mandate when it refuses to cover a qualifying EPSDT service. A state would unlawfully fail to provide coverage of a treatment if:
(1) a prescribed treatment is designed to correct or ameliorate defects, physical or mental illnesses, or conditions discovered through EPSDT screening;
(2) the state, or its Medicaid program, excludes coverage or denied payment of that treatment; and
(3) the state, or its Medicaid program, acted unreasonably when it determined that the prescribed treatment is experimental or otherwise disqualifying.
Plaintiffs allege that Applied Behavior Analysis ("ABA") is an effective form of treatment for children and young adults who have autism.
In August 2014, the Department's Medicaid administrator, Dr. Kenneth Fink ("Dr. Fink"), reviewed a report from the federal Agency for Healthcare Research and Quality regarding ABA. (Fink Depo. at 159:14-161:8, Ex. 2 of Plas. Amended CSF, ECF No. 104-5; Aug. 2014 Agency for Healthcare Research and Quality Report, Ex. 15 of Plas. Amended CSF, ECF No. 104-18). The report concluded that ABA was evidence-based and an effective form of treatment for autism. (Ex. 15 of Plas. Amended CSF at p. 9). The uncontroverted evidence presented before the Court establishes that the report's analysis convinced Dr. Fink that there was sufficient research to support Medicaid coverage of ABA. (Fink Depo. at 159:14-161:8, Ex. 2 of Plas. Amended CSF).
Despite the fact that the Department recognized ABA as a valid form of treatment, Department officials failed to inform the Medicaid health plans that it considered ABA to be effective until January 2015. (Jan. 13, 2015 Department Memo., Ex. 12 of Def. Amended CSF, ECF No. 103-15). The Department did not issue specific instructions concerning processing of ABA claims until August 2015, six months after issuing a formal policy position and twelve months after the Department accepted ABA as a valid form of treatment for autism. (Aug. 28, 2015 Department Memo., Ex. 13 of Def. Amended CSF, ECF No. 103-16).
There was a twelve-month delay between the Department's acceptance of ABA treatment and the promulgation of specific instructions to the Medicaid health plans. The Medicaid Act requires participating states to provide medical assistance "with reasonable promptness to all eligible individuals." 42 U.S.C. § 1396a(a)(8). Federal regulations interpreting the Medicaid Act require participating states to "[f]urnish Medicaid promptly to recipients without any delay caused by the agency's administrative procedures." 42 C.F.R. § 435.930(a). A period of twelve months is significant for children whose development depends on effective treatment for the serious condition of autism. Defendant has provided no reasonable explanation as to why the twelve-month delay was necessary.
The Court finds that the Department excluded ABA treatment from Medicaid Coverage from August 2014 to August 2015.
A federal court does not have authority to render opinions as to questions that have become moot.
The key inquiry with respect to a mootness issue is whether there can be any effective relief.
Plaintiffs' claim that the Department currently excludes ABA from Medicaid coverage is moot. Plaintiffs concede that since August 2015, J.E. has been receiving his full dosage of prescribed ABA treatment, and that the treatment is covered by Medicaid. (Egan Decl. at ¶ 44, ECF No. 104-2). The evidence presented establishes that the Department presently endorses Medicaid coverage of ABA. There is no indication that the state Medicaid program excludes or will exclude ABA from coverage.
Plaintiffs argue that their claim is still live, as the Department has voluntarily ceased its practice of excluding ABA treatment. (Plas. Opp. at pp. 13-16, ECF No. 111). Plaintiffs' chief objection to a mootness finding is that "there are no assurances that this coverage is permanent." (Plas. Motion for Summary Jdgmt. at p. 37, ECF No. 100).
The appellate courts have recognized that a defendant's voluntary cessation of a challenged practice may preclude a court from finding the case moot, as doing so may set the defendant "free to return to his old ways."
The evidence presented shows that in August 2014, the Department began a reexamination of ABA treatment as a medically necessary treatment for autism.
In August 2014, the federal Agency for Healthcare Research and Quality published a report that described ABA as evidence-based and effective. (Ex. 15 of Plas. Amended CSF at p. 9, ECF No. 104-18). The report's analysis convinced Dr. Fink that there was sufficient research to support coverage of ABA. (Fink Depo. at 159:14-161:8, Ex. 2 of Plas. Amended CSF). By August 26, 2014, Dr. Fink started plans to articulate a formal Department policy recognizing ABA treatment. (Aug. 26, 2014 E-Mail from Dr. Fink, Ex. 17 of Plas. Amended CSF, ECF No. 104-20).
In early December 2014, officials from the Department drafted a one-page memorandum indicating that health plans should cover ABA treatment under the EPSDT mandate. (Ex. 21 of Plas. Amended CSF at Bates No. DHS 2467, ECF No. 104-24). Dr. Fink rejected the draft memorandum, citing the need "to finalize our guideline[,] which is being issued for consistency and clarity." (
On December 18, 2014, the Department's Medicaid Medical Director informed the health plans' medical directors that "[p]atients with Autistic Spectrum Disorder can benefit from Applied Behavior Analysis (ABA) therapy. We are currently working on draft guidance regarding ABA and would appreciate any feedback on your part." (Dec. 18, 2014 E-Mail from Dr. Curtis Toma, Ex. 22 of Plas. Amended CSF, ECF No. 104-25; Fink Depo. at 90:15-91:15, Ex. 2 of Plas. Amended CSF).
In January 2015, the Governor of Hawaii proposed an increase in the Department's budget for fiscal years 2016 and 2017 by $5.6 million and $5.5 million, respectively. (Amendments to 2015-2017 Exec. Biennium Budget, Ex. 24 of Plas. Amended CSF, ECF No. 104-27). The budget increase was meant to account for the expected increase in services for Medicaid recipients with autism, including ABA treatment. (
On January 13, 2015, the Department issued a memorandum to Medicaid health plans and service providers suggesting that the Department viewed ABA treatment favorably. Citing to the August 2014 report by the Agency for Healthcare Research and Quality, the memorandum concluded that ABA treatment is effective. (Ex. 12 of Def. Amended CSF at Bates No. DHS 5852, ECF No. 103-15). The Department provided general instructions as to how autism treatment claims may be processed. The memorandum contained information regarding appropriate billing codes for autism treatments. The memorandum did not request any action to notify patients of the change in the Department's position. It stated, "[w]e will be working with the community to make revisions to this clarification guidance." (
On August 28, 2015, the Department sent a detailed superseding memorandum to its Medicaid health plans and service providers. The memorandum stated that "Hawaii's [Medicaid] health plans must comply with the full range of EPSDT duties and requirements, . . . including ABA [treatment], for children under 21 years of age with [autsim], when based on individualized determinations of medical necessity." (Ex. 13 of Def. Amended CSF at p. 1, ECF No. 103-16). The superseding memorandum included four attachments, which provided extensive detail regarding how health plans should approach ABA claims. (
On December 22, 2015, the state Department of Budget and Finance designated an additional $4.9 million to help the Department cover autism-related treatments for Medicaid for fiscal year 2017. (2017 Exec. Supp. Budget, Ex. 31 of Plas. Amended CSF, ECF No. 104-34).
Defendant has demonstrated that the Department's internal discussions, external communications with the Medicaid health plans, and formal memoranda outlining the Department's acceptance of ABA treatment "[make] it absolutely clear that the allegedly wrongful behavior [cannot] reasonably be expected to recur."
The August 2015 memorandum represents a permanent change in the way the Department views ABA treatment.
The state government currently shows a favorable disposition towards ABA. In addition to its allocation of approximately $15 million to pay for Medicaid coverage of autism-related services, the state government has also mandated private health insurance plans to cover autism treatments, including ABA.
The Ninth Circuit Court of Appeals has recognized that "unlike in the case of a private party, we presume the government is acting in good faith."
"The mere possibility that a party may suffer future harm is insufficient to preserve a case or controversy; the threat of injury must be `real and immediate,' not `conjectural' or `hypothetical.'"
Plaintiffs argue that the Department must amend its Medicaid State Plan, so that the State Plan specifically mentions ABA as a covered treatment. (Plas. Opp. at pp. 11; 15, ECF No. 111). Plaintiffs do not point to a provision of the Medicaid Act, or its accompanying regulations, that require a State Plan to include specific treatments covered by the EPSDT services mandate. Defendant, in contrast, has presented a communication from the Centers for Medicaid and Medicare Services, which stated that "CMS encourages states not to call out a particular model of ASD treatment modalities, such as `ABA-based therapies'. We ask states to use more general terms, such as `Intensive Behavioral Therapies.'" (Ex. 18 of Def. Reply, ECF No. 117-3) (emphasis added). On June 29, 2015, the Department submitted a State Plan Amendment that references Intensive Behavioral Therapy as a permitted form of treatment for autism. (Ex. 10 of Plas. Amended CSF in Opp., ECF No. 112-12). Plaintiffs have not produced evidence indicating that a State Plan Amendment referencing ABA is necessary in this case.
Defendant's Motion for Summary Judgment seeking a declaratory judgment that it has always covered medically necessary autism treatment is
Plaintiffs' claims seeking prospective relief on the basis that the Department may exclude ABA treatment in the future is
In addition to providing early and periodic screening, diagnostic, and treatment ("EPSDT") services, a participating state must also ensure that persons eligible to receive EPSDT services are informed of the EPSDT program. The Medicaid Act provides that the state is responsible for "informing all persons in the State who are under the age of 21 and who have been determined to be eligible for medical assistance . . . of the availability of early and periodic screening, diagnostic, and treatment services . . . and the need for age-appropriate immunizations against vaccine-preventable diseases[.]" 42 U.S.C. § 1396a(a)(43)(A).
The Court previously ruled that 42 U.S.C. § 1983 provides a private cause of action to enforce a Medicaid recipient's rights pursuant to 42 U.S.C. § 1396(a)(43)(A). (Order Denying Defendant's Motion to Dismiss Second Amended Complaint, ECF No. 62);
The statutory mandate demands a proactive approach. A participating state "is supposed to seek out eligible individuals and inform them of the benefits of prevention and the health services and assistance available."
The Medicaid Act's outreach obligation is comprised of three aspects: form, content, and frequency.
Federal regulations require participating states to use "a combination of written and oral methods designed to inform effectively all EPSDT eligible individuals (or their families) about the EPSDT program." 42 C.F.R. § 441.56(a)(1). Examples of methods that may provide effective outreach include mailed notices, public service announcements, public presentations, and community advocacy that addresses the target population.
Communications regarding ESPDT services must be presented in plain terms. 42 C.F.R. § 441.56(a)(2). To comply with this obligation, the participating state should routinely assess its outreach methods, and may have to change its approach to ensure that the beneficiaries are effectively informed of the EPSDT program.
Communications should apprise eligible persons of the nature of the early and periodic screening, diagnosis, and treatment ("EPSDT") program (including the fact that it is cost-free in most cases), services available under the program, and where and how they may obtain EPSDT services. 42 C.F.R. §441.56(a)(2)(ii);
Federal law affords some flexibility to state Medicaid programs with respect to the amount and specificity of information they must provide to the beneficiaries.
The Medicaid Act requires the participating state to provide accurate and up-to-date information to EPSDT-eligible persons.
Where, as here, a Medicaid beneficiary files suit and shows that there is significant and widespread confusion about the Medicaid program's coverage of an EPSDT service, the state is on notice that its outreach efforts are inadequate. The lawsuit demonstrates that there is a clear need for an update to the contents of the state's communications.
Federal regulations provide clear instructions regarding when, and how often, a state Medicaid program must disseminate its EPSDT notices. The state must provide the relevant information "within 60 days of the individual's initial Medicaid eligibility determination and in the case of families which have not utilized EPSDT services, annually thereafter." 42 C.F.R. § 441.56(a)(4).
Plaintiffs claim that the Department has failed to fulfill its obligation to ensure that eligible recipients are informed of "services available under the EPSDT program and where and how to obtain those services," by failing to announce that Applied Behavior Analysis ("ABA") treatment is covered by Medicaid. 42 C.F.R. § 441.56(a)(2)(ii).
Defendant demurs by asserting that the Medicaid Act requires the Department "to simply pass on general information about the availability of EPSDT as a program to the eligible beneficiaries." (Def. Motion for Summary Jdgmt. at pp. 14-15, ECF No. 98-1). The Department cites the logistical complexity associated with notifying its 300,000 Medicaid beneficiaries, and asserts that in any case, it has contracted the obligation to provide information about EPSDT services to various third-party Medicaid health plans, as permitted under the managed care system. (
Defendant presented evidence that in January 2015, J.E. (through his mother) received a "Welcome Kit" from UnitedHealthcare, a Medicaid health plan. The Welcome Kit included general information about EPSDT services, but did not reference autism-related treatments or provide updates concerning Medicaid coverage. (Sealed Ex. 4 of Def. Amended CSF at Bates Nos. E000582; E000605; E000684-85).
Plaintiffs have submitted evidence establishing that in the past, the Department publically announced its opposition to the coverage of ABA.
In January 2013, the State Legislative Reference Bureau reported that Hawaii's Medicaid program did not cover ABA, as the treatment was not considered evidence-based or medically necessary. That report's conclusion was based on an interview with the Department's Medicaid administrator, Dr. Fink. (Ex. 6 of Plas. Amended CSF, ECF No. 104-9; Fink Depo. at 148:16-149:8, Ex. 2 of Plas. Amended CSF).
In April 2013, the then-director of the Department, Patricia McManaman ("Director McManaman"), testified before the state legislature in opposition to a state bill that would require health insurers to provide coverage for ABA treatment. Director McManaman stated that ABA treatment was "not currently covered by the Hawaii Medicaid program." (Ex. 7 of Plas. Amended CSF at p. 1, ECF No. 104-10).
In March 2014, Director McManaman again presented testimony before the state legislature. She expressed support "for the intent of the coverage" of ABA, but questioned whether sufficient evidence to support the effectiveness ABA treatment existed at that time. (Ex. 12 of Plas. Amended CSF at pp. 2-3, ECF No. 104-15).
The evidence presented establishes that since August 2014, the Department has stated it has embarked on adopting a policy that allows for Medicaid coverage of ABA treatment. (
There is no indication, however, that the Department has informed persons eligible for EPSDT services about its changed policy as to ABA. Plaintiffs have produced evidence indicating that eligible Medicaid beneficiaries such as J.E. have "not received pamphlets, information, or heard any public announcements that the [ABA] treatment is officially covered." (Egan Decl. at ¶ 46; Erteschik Supp. Decl. at ¶ 18). The Hawaii Disability Rights Center reports that its constituents are unsure as to whether the Medicaid program covers ABA treatment. (Bassett Decl. at ¶ 11, ECF No. 122-4). Parents who sought ABA treatment for their autistic children before the Department reversed its policy were never informed of the Department's changed position. (Tachera Decl. at ¶¶ 49-52, ECF No. 122-3).
The Department has failed to uphold its duty to correct out-of-date or inaccurate information previously disseminated to the beneficiaries.
The Department must notify persons eligible for EPSDT services of the fact that ABA is now recognized as a covered treatment for autism under the state Medicaid program.
If the Department elects to delegate the task to the third-party Medicaid health plans, it still has the responsibility to ensure that the health plans' outreach efforts are effective and comply with federal law.
Plaintiffs' Motion for Summary Judgment as to the claim that the Department did not fulfill its statutory obligation to effectively inform Medicaid beneficiaries of EPSDT services is
Between August 2014 and August 2015, the State of Hawaii, Department of Human Services ("the Department") delayed in instructing Medicaid health plans to cover claims for Applied Behavior Analysis ("ABA"), despite the Medicaid Act's early and periodic screening, diagnostic and treatment ("EPSDT") mandate, 42 U.S.C. § 1396 et seq., and despite recognizing ABA treatment's effectiveness and qualification for Medicaid coverage.
Since August 2015, the Department has had a policy and practice of covering ABA as a medically necessary treatment under the state's Medicaid program. The Department's current policy concerning Medicaid coverage of ABA is permanent. There is no reasonable likelihood that the Department will reverse its position in the future.
An amendment to the Medicaid State Plan to reflect the Department's position as to ABA is not required.
The Department of Human Services did not fulfill the Medicaid Act's requirement that eligible persons be informed effectively of EPSDT services. The Department has a duty to correct out-of-date or inaccurate information that it previously disseminated. The Department must notify persons eligible for EPSDT services of the fact that ABA is now recognized as a covered treatment for autism under the state Medicaid program.
Plaintiffs J.E., through his parent, Suzanne Egan, and the Hawaii Disability Rights Center's Motion for Summary Judgment (ECF No. 100) is
Defendant Rachael Wong, in her official capacity as Director of the Department of Human Services' Motion for Summary Judgment (ECF No. 98) is
Plaintiffs have requested an award of reasonable costs and attorneys' fees. 42 U.S.C. § 1988 permits the Court to award reasonable attorneys' fees to the prevailing party of an action pursuant to 42 U.S.C. § 1983. 42 U.S.C. § 1988(b);
The Court finds that Plaintiffs are the prevailing party in this action, as they achieved a judicially-sanctioned material alteration of the legal relationship of the parties through this Court's entry of summary judgment compelling the Department to publicize the Medicaid program's coverage of ABA treatment.
The Court, in the exercise of its broad discretion, grants Plaintiffs' request for an award of reasonable costs and attorneys' fees. Plaintiffs are entitled to attorneys' fees in presenting their entire case, even though there are issues that are either unresolved or on which Plaintiffs did not prevail.
IT IS SO ORDERED.